NASDAQ: CRVO - CervoMed Inc.

Yield per half year: -86.19%
Dividend yield: 0.00%
Sector: Healthcare

Share chart CervoMed Inc.

Extended chart Simple chart
Financial Markets by TradingView

About CervoMed Inc.

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2016-01-04
ISIN US15713L1098
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.cervomed.com
Цена ао 2.22
Change price per day: +2.75% (2.18)
Change price per week: -1.75% (2.28)
Change price per month: -1.75% (2.28)
Change price per 3 month: -79.26% (10.8)
Change price per half year: -86.19% (16.22)
Change price per year: -82.66% (12.92)
Change price per 3 year: +662.16% (0.2939)
Change price per 5 year: +357.33% (0.4898)
Change price per 10 year: 0% (2.24)
Change price per year to date: +15.46% (1.94)
All parameters

Underestimation

Title Value Grade
P/S 2.51 6
P/BV 2.43 6
P/E 0 0
EV/EBITDA -1.3 0
Total: 5.25

Efficiency

Title Value Grade
ROA, % -21.78 0
ROE, % -29.44 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % -81.11 0
Yield EPS, % -95.37 0
Total: 0
More

Institutions Volume Share, %
Adage Capital Partners GP L.L.C. 199347 3.23
CWM, LLC 59088 0.96
Renaissance Technologies, LLC 29033 0.47
Blackrock Inc. 21900 0.35
Vanguard Group Inc 19916 0.32
Geode Capital Management, LLC 15709 0.25
Hoey Investments, INC. 1080 0.02
Tower Research Capital LLC (TRC) 725 0.01
Osaic Holdings Inc 395 0.01
HARBOUR INVESTMENTS, INC. 66 0

ETFShare, %Profitability for 1 year, %Dividends, %
iShares Micro-Cap ETF 0.02299 17.09 1.54048
iShares Russell 2000 Growth ETF 0.00673 38.04 0.6026
0.0127.571.07



Head Job title Payment Year of birth
Dr. Sylvie L. Gregoire Pharm.D. Co-Founder & Director 352.43k 1961 (64 years)
Dr. John J. Alam M.D. Co-Founder, CEO, President & Director 680.25k 1962 (63 years)
Dr. Robert J. Cobuzzi Jr., Ph.D. COO & Director 386.6k 1965 (60 years)
Mr. William Robert Elder J.D. CFO & General Counsel 407.55k 1983 (42 years)
Ms. Kelly Blackburn M.H.A. Senior Vice President of Clinical Development 404.94k 1964 (61 year)

Address: United States, Boston. MA, 20 Park Plaza - open in Google maps, open in Yandex maps
Website: https://www.cervomed.com